Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

U.S. senators questioned Novo Nordisk CEO Lars Fruergaard Jørgensen about the high costs of the company's GLP-1 drugs, which include popular weight-loss drugs Wegovy and Ozempic. It comes after North ...

Novo Nordisk CEO commits to exploring ways to make weight-loss drugs more affordable for U.S. patients after hearing from ...

Our editors also may be in touch with follow-up questions. Due to a Wegovy shortage coupled with Ozempic’s weight loss effects going viral on social media, people without type 2 diabetes have ...

Jon Gosselin detailed the ebbs and flows of his weight-loss journey, which included semaglutide and weight gain, but he's back on track, thanks to a new treatment.

But if weight loss drugs can improve cardiometabolic health, as it seems they can, and fulfil even half of what is being claimed for them, then this must be one of the biggest breakthroughs in medical ...

WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

Novo Nordisk has struck back in its growing rivalry with Eli Lilly in the obesity market, with data showing a higher-dose version of its oral version of weight loss drug Wegovy hit the mark in a ...